Sotac Pharmaceuticals Complete Financial Statements
SOTAC • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Sotac Pharmaceuticals (SOTAC).
Downloads include all available records across all periods.
For market performance, see the
SOTAC stock price today
.
Profitability Ratios
Net Profit Margin
3.57%
2024 data
EBITDA Margin
10.71%
2024 data
Operating Margin
8.00%
2024 data
Return on Assets
0.81%
2024 data
Return on Equity
1.72%
2024 data
Balance Sheet Ratios
Current Ratio
5.00
2024 data
Debt to Equity
2.14
2024 data
Equity Ratio
46.77%
2024 data
Asset Turnover
0.23
2024 data
Year-over-Year Growth Analysis
Comparing Sept 2023 vs Sept 2024
Revenue Growth
+3.7%
Year-over-Year
EBITDA Growth
+50.0%
Year-over-Year
Assets Growth
+18.1%
Year-over-Year
Equity Growth
+18.4%
Year-over-Year
Liabilities Growth
+18.1%
Year-over-Year
Operating Cash Flow Growth
+75.0%
Year-over-Year
Investing Cash Flow Growth
+30.0%
Year-over-Year
Financing Cash Flow Growth
-46.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2024 | Mar 2024 | Jun 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28 | 27 | 26 | 27 | 18 | 25 | 26 | 41 | 20 |
| Expenses | 25 | 25 | 23 | 25 | 16 | 23 | 23 | 36 | 18 |
| EBITDA | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 4 | 2 |
| Operating Profit Margin % | 8.00% | 4.00% | 9.00% | 8.00% | 13.00% | 9.00% | 10.00% | 9.00% | 9.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 1 |
| Tax | 1 | -1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Net Profit | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Earnings Per Share (₹) | 0.42 | 1.49 | 1.32 | 0.58 | 1.58 | 1.01 | 0.82 | 4.41 | 0.29 |
Related Pages for Sotac Pharmaceuticals
Additional stock information and data for SOTAC
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 124 | 105 | 74 | 35 | 30 |
| Current Assets | 70 | 61 | 47 | 17 | 14 |
| Fixed Assets | 49 | 36 | 26 | 17 | 16 |
| Capital Work in Progress | 0 | 5 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 75 | 65 | 48 | 18 | 14 |
| LIABILITIES | |||||
| Total Liabilities | 124 | 105 | 74 | 35 | 30 |
| Current Liabilities | 14 | 12 | 8 | 9 | 6 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 58 | 49 | 20 | 3 | 5 |
| Share Capital | 11 | 11 | 8 | 2 | 2 |
| Reserves & Surplus | 42 | 34 | 2 | 0 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2021 | March 2020 |
|---|---|---|---|---|---|
| Operating Activities | -4 | -16 | 8 | 0 | 0 |
| Investing Activities | -14 | -20 | -12 | -3 | -12 |
| Financing Activities | 16 | 30 | 13 | 3 | 11 |
| Net Cash Flow | -2 | -6 | 10 | 0 | 0 |